Aceto reported 15.64M in Operating Expenses for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Acasti Pharma ACST:US C$ 2.42M 5.62M
Aceto ACET:US 15.64M 1.73M
Agile Therapeutics AGRX:US 17.84M 1.5M
Glaxosmithkline GSK:US 6.42B 692M
Idera Pharmaceuticals IDRA:US $ 7.56M 2.47M
Merk MRK:US $ 9905M 839M
Novartis NVS:US 9.82B 464M
Pain Therapeutics PTIE:US $ 5.14M 1.6M
Pfizer PFE:US $ 13063M 3998M
Prestige Brands PBH:US $ 177.84M 1.31M